Tilray Brands (TLRY) EBT Margin Growth (3y) (2023 - 2026)
Tilray Brands (TLRY) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,840.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -134.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,626.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,686.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,570.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5,487.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -225.00 |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 81,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 81,750.00 |
| Nov 30, 2025 | 3,251.00 |
| Aug 31, 2025 | 3,787.00 |
| May 31, 2025 | -45,434.00 |
| Feb 28, 2025 | -45,984.00 |
| Nov 30, 2024 | -3,954.00 |
| Aug 31, 2024 | 88.00 |
| May 31, 2024 | -22,953.00 |
| Feb 29, 2024 | 14,639.00 |
| Nov 30, 2023 | 5,432.00 |
| Aug 31, 2023 | -400.00 |
| May 31, 2023 | 43,676.00 |